Search

Search Constraints

You searched for: Date 2018 Author/Creator Ferrante, M

Search Results

1. 740PFinal results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC. (23rd October 2018)

2. DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn's and Colitis Organisation study. (16th January 2018)

5. Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study. Issue 5 (23rd April 2018)

6. O-003Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC). (20th June 2018)

7. O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results. (20th June 2018)

9. OP032 Outcome of pregnancies in female IBD patients treated with vedolizumab. (16th January 2018)

10. P010 Serum proteomic profiling in Crohn's disease patients undergoing ileocolonic resection reveals discriminative inflammatory markers for endoscopic recurrence. (16th January 2018)